Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 3/2018

01-06-2018 | Review

Evaluation and management of Staphylococcus aureus bacteriuria: an updated review

Authors: Stamatis Karakonstantis, Dimitra Kalemaki

Published in: Infection | Issue 3/2018

Login to get access

Abstract

Background and aims

There is little guidance regarding the evaluation and management of patients with Staphylococcus aureus bacteriuria (SABU). Here, we aimed to provide an up-to-date review of the literature.

Methods

We searched PubMed, Scopus, and clinical trial registries for articles evaluating the epidemiology of SABU, risk factors of SABU, the association of SABU with urinary tract infection, bacteremia and invasive S. aureus infections, and the management of patients with SABU.

Results

S. aureus is an uncommon isolate in urine cultures. It is more common among certain patients, e.g., patients with indwelling urinary tract devices or prior urinary tract instrumentation. SABU may represent asymptomatic bacteriuria, primary urinary tract infection, or hematogenous seeding of the urinary tract associated with other foci of infection. SABU may also serve as the focus for subsequent bacteremia and invasive infections. We did not find any clinical trials regarding the management of patients with SABU.

Conclusions

Based on our review, we suggest an algorithmic approach for the evaluation and management of patients with SABU. However, evidence from clinical trials is lacking and there are several gaps in the current literature. These are discussed in this review.
Appendix
Available only for authorised users
Literature
1.
Looney AT, Redmond EJ, Davey NM, Daly PJ, Troy C, Carey BF, et al. Methicillin-resistant Staphylococcus aureus as a uropathogen in an Irish setting. Medicine (Baltimore). 2017;96:e4635.CrossRef
2.
Al Mohajer M, Musher DM, Minard CG, Darouiche RO. Clinical significance of Staphylococcus aureus bacteriuria at a tertiary care hospital. Scand J Infect Dis. 2013;45:688–95.CrossRefPubMed
3.
Al Mohajer M, Darouiche RO. Staphylococcus aureus bacteriuria: source, clinical relevance, and management. Curr Infect Dis Rep. 2012;14:601–6.CrossRefPubMed
4.
Arpi M, Renneberg J. The clinical significance of Staphylococcus aureus bacteriuria. J Urol. 1984;132:697–700.CrossRefPubMed
5.
Ekkelenkamp MB, Verhoef J, Bonten MJ. Quantifying the relationship between Staphylococcus aureus bacteremia and S. aureus bacteriuria: a retrospective analysis in a tertiary care hospital. Clin Infect Dis. 2007;44:1457–9.CrossRefPubMed
6.
Routh JC, Alt AL, Ashley RA, Kramer SA, Boyce TG. Increasing prevalence and associated risk factors for methicillin resistant Staphylococcus aureus bacteriuria. J Urol. 2009;181:1694–8.CrossRefPubMed
7.
Chiu CC, Lin TC, Wu RX, Yang YS, Hsiao PJ, Lee Y et al. Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms. J Microbiol Immunol Infect. 2016.
8.
Armbruster CE, Prenovost K, Mobley HL, Mody L. How often do clinically diagnosed catheter-associated urinary tract infections in nursing homes meet standardized criteria? J Am Geriatr Soc. 2017;65:395–401.CrossRefPubMed
9.
Ackermann RJ, Monroe PW. Bacteremic urinary tract infection in older people. J Am Geriatr Soc. 1996;44:927–33.CrossRefPubMed
10.
Sheth S, DiNubile MJ. Clinical significance of Staphylococcus aureus bacteriuria without concurrent bacteremia. Clin Infect Dis. 1997;24:1268–9.CrossRefPubMed
11.
Lee BK, Crossley K, Gerding DN. The association between Staphylococcus aureus bacteremia and bacteriuria. Am J Med. 1978;65:303–6.CrossRefPubMed
12.
Huggan PJ, Murdoch DR, Gallagher K, Chambers ST. Concomitant Staphylococcus aureus bacteriuria is associated with poor clinical outcome in adults with S. aureus bacteraemia. J Hosp Infect. 2008;69:345–9.CrossRefPubMed
13.
Asgeirsson H, Kristjansson M, Kristinsson KG, Gudlaugsson O. Clinical significance of Staphylococcus aureus bacteriuria in a nationwide study of adults with S. aureus bacteraemia. J Infect. 2012;64:41–6.CrossRefPubMed
14.
Choi SH, Lee SO, Choi JP, Lim SK, Chung JW, Choi SH, et al. The clinical significance of concurrent Staphylococcus aureus bacteriuria in patients with S. aureus bacteremia. J Infect. 2009;59:37–41.CrossRefPubMed
15.
Pulcini C, Matta M, Mondain V, Gaudart A, Girard-Pipau F, Mainardi JL, et al. Concomitant Staphylococcus aureus bacteriuria is associated with complicated S. aureus bacteremia. J Infect. 2009;59:240–6.CrossRefPubMed
16.
Manandhar S, Pai G, Gidwani H, Nazim S, Buehrle D, Shutt KA, et al. Does Staphylococcus aureus bacteriuria predict clinical outcomes in patients with bacteremia?: analysis of 274 patients with Staphylococcus aureus blood stream infection. Infect Dis Clin Pract. 2016;24:151–4.CrossRef
17.
Perez-Jorge EV, Burdette SD, Markert RJ, Beam WB. Staphylococcus aureus bacteremia (SAB) with associated S. aureus bacteriuria (SABU) as a predictor of complications and mortality. J Hosp Med. 2010;5:208–11.CrossRefPubMed
18.
Coello R, Jimenez J, Garcia M, Arroyo P, Minguez D, Fernandez C, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis. 1994;13:74–81.CrossRefPubMed
19.
Muder RR, Brennen C, Rihs JD, Wagener MM, Obman A, Stout JE, et al. Isolation of Staphylococcus aureus from the urinary tract: association of isolation with symptomatic urinary tract infection and subsequent Staphylococcal bacteremia. Clin Infect Dis. 2006;42:46–50.CrossRefPubMed
20.
Baraboutis IG, Tsagalou EP, Lepinski JL, Papakonstantinou I, Papastamopoulos V, Skoutelis AT, et al. Primary Staphylococcus aureus urinary tract infection: the role of undetected hematogenous seeding of the urinary tract. Eur J Clin Microbiol Infect Dis. 2010;29:1095–101.CrossRefPubMed
21.
Gibson KE, McNamara SE, Cassone M, Perri MB, Zervos M, Mody L, et al. Methicillin-resistant Staphylococcus aureus: site of acquisition and strain variation in high-risk nursing home residents with indwelling devices. Infect Control Hosp Epidemiol. 2014;35:1458–65.CrossRefPubMedPubMedCentral
22.
Sapico FL, Montgomerie JZ, Canawati HN, Aeilts G. Methicillin-resistant Staphylococcus aureus bacteriuria. Am J Med Sci. 1981;281:101–9.CrossRefPubMed
23.
Coll PP, Crabtree BF, O’Connor PJ, Klenzak S. Clinical risk factors for methicillin-resistant Staphylococcus aureus bacteriuria in a skilled-care nursing home. Arch Fam Med. 1994;3:357–60.CrossRefPubMed
24.
Ajayi AB, Nwabuisi C, Aboyeji AP, Ajayi NS, Fowotade A, Fakeye OO. Asymptomatic bacteriuria in antenatal patients in ilorin, Nigeria. Oman Med J. 2012;27:31–5.CrossRefPubMedPubMedCentral
25.
Hamdan HZ, Ziad AH, Ali SK, Adam I. Epidemiology of urinary tract infections and antibiotics sensitivity among pregnant women at Khartoum North Hospital. Ann Clin Microbiol Antimicrob. 2011;10:2.CrossRefPubMedPubMedCentral
26.
Omoregie R, Erebor JO, Ahonkhai I, Isibor JO, Ogefere HO. Observed changes in the prevalence of uropathogens in Benin City, Nigeria. N Z J Med Lab Sci. 2008;62:29–31.
27.
28.
Schneeberger C, Kazemier BM, Geerlings SE. Asymptomatic bacteriuria and urinary tract infections in special patient groups: women with diabetes mellitus and pregnant women. Curr Opin Infect Dis. 2014;27:108–14.CrossRefPubMed
29.
Chihara S, Popovich KJ, Weinstein RA, Hota B. Staphylococcus aureus bacteriuria as a prognosticator for outcome of Staphylococcus aureus bacteremia: a case–control study. BMC Infect Dis. 2010;10:225.CrossRefPubMedPubMedCentral
30.
Takahashi S, Hirose T, Takeyama K, Satoh T, Tsukamoto T. Follow up of urology patients discharged with urinary methicillin-resistant Staphylococcus aureus. J Hosp Infect. 1997;37:249–51.CrossRefPubMed
31.
Saidel-Odes L, Riesenberg K, Schlaeffer F, Borer A. Epidemiological and clinical characteristics of methicillin sensitive Staphylococcus aureus (MSSA) bacteriuria. J Infect. 2009;58:119–22.CrossRefPubMed
32.
Ninan S, Walton C, Barlow G. Investigation of suspected urinary tract infection in older people. BMJ. 2014;349:g4070.CrossRefPubMed
33.
Orr PH, Nicolle LE, Duckworth H, Brunka J, Kennedy J, Murray D, et al. Febrile urinary infection in the institutionalized elderly. Am J Med. 1996;100:71–7.CrossRefPubMed
34.
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13:269–84.CrossRefPubMedPubMedCentral
35.
Demuth PJ, Gerding DN, Crossley K. Staphylococcus aureus bacteriuria. Arch Intern Med. 1979;139:78–80.CrossRefPubMed
36.
Anderson DJ, Kaye KS, Sexton DJ. Methicillin-resistant Staphylococcus aureus bacteremia after isolation from urine. Clin Infect Dis. 2006;42:1504–5.CrossRefPubMed
37.
Paulsen J, Mehl A, Askim A, Solligard E, Asvold BO, Damas JK. Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996–2011: an observational study. BMC Infect Dis. 2015;15:116.CrossRefPubMedPubMedCentral
38.
Pien BC, Sundaram P, Raoof N, Costa SF, Mirrett S, Woods CW, et al. The clinical and prognostic importance of positive blood cultures in adults. Am J Med. 2010;123:819–28.CrossRefPubMed
39.
Khatib R, Schaffer C, Johnson LB. Staphylococcus aureus in a single positive blood culture: causes and outcome. Scand J Infect Dis. 2002;34:645–7.CrossRefPubMed
40.
Goto M, Schweizer ML, Vaughan-Sarrazin MS, Perencevich EN, Livorsi DJ, Diekema DJ, et al. Association of evidence-based care processes with mortality in Staphylococcus aureus bacteremia at Veterans Health Administration hospitals, 2003–2014. JAMA Intern Med. 2017;177:1489–97.CrossRefPubMedPubMedCentral
41.
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18–55.CrossRefPubMed
42.
Thwaites GE, Edgeworth JD, Gkrania-Klotsas E, Kirby A, Tilley R, Torok ME, et al. Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect Dis. 2011;11:208–22.CrossRefPubMed
43.
44.
Kaasch AJ, Fowler VG Jr, Rieg S, Peyerl-Hoffmann G, Birkholz H, Hellmich M, et al. Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia. Clin Infect Dis. 2011;53:1–9.CrossRefPubMedPubMedCentral
45.
Kaasch AJ, Fatkenheuer G, Prinz-Langenohl R, Paulus U, Hellmich M, Weiss V, et al. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial. Trials. 2015;16:450.CrossRefPubMedPubMedCentral
46.
Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603–61.CrossRefPubMedPubMedCentral
47.
Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40:643–54.CrossRefPubMed
48.
Cai T, Nesi G, Mazzoli S, Meacci F, Lanzafame P, Caciagli P, et al. Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections. Clin Infect Dis. 2015;61:1655–61.PubMed
49.
Acton DS, Plat-Sinnige MJ, van Wamel W, de Groot N, van Belkum A. Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact? Eur J Clin Microbiol Infect Dis. 2009;28:115–27.CrossRefPubMed
50.
Buehlmann M, Frei R, Fenner L, Dangel M, Fluckiger U, Widmer AF. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect Control Hosp Epidemiol. 2008;29:510–6.CrossRefPubMed
51.
Gagnaire J, Verhoeven PO, Grattard F, Rigaill J, Lucht F, Pozzetto B, et al. Epidemiology and clinical relevance of Staphylococcus aureus intestinal carriage: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2017;15:767–85.CrossRefPubMed
52.
Huang SS, Septimus E, Hayden MK, Kleinman K, Sturtevant J, Avery TR, et al. Effect of body surface decolonisation on bacteriuria and candiduria in intensive care units: an analysis of a cluster-randomised trial. Lancet Infect Dis. 2016;16:70–9.CrossRefPubMed
53.
Nishida S. Effect of Hochu-ekki-to on asymptomatic MRSA bacteriuria. J Infect Chemother. 2003;9:58–61.CrossRefPubMed
54.
Bocher S, Skov RL, Knudsen MA, Guardabassi L, Molbak K, Schouenborg P, et al. The search and destroy strategy prevents spread and long-term carriage of methicillin-resistant Staphylococcus aureus: results from the follow-up screening of a large ST22 (E-MRSA 15) outbreak in Denmark. Clin Microbiol Infect. 2010;16:1427–34.CrossRefPubMed
55.
Pan A, Lee A, Cooper B, Chalfine A, Daikos GL, Garilli S, et al. Risk factors for previously unknown meticillin-resistant Staphylococcus aureus carriage on admission to 13 surgical wards in Europe. J Hosp Infect. 2013;83:107–13.CrossRefPubMed
56.
Saravolatz LD, WaaecrMDSaBPCOiPW Bacter, et al. Does Staphylococcus aureus bacteriuria influence outcome in patients with Staphylococcus aureus bacteremia? Infect Dis Clin Pract. 2016;24:131–2.CrossRef
Metadata
Title
Evaluation and management of Staphylococcus aureus bacteriuria: an updated review
Authors
Stamatis Karakonstantis
Dimitra Kalemaki
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2018
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1100-6

Other articles of this Issue 3/2018

Infection 3/2018 Go to the issue

Review

Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection

Original Paper

Management of superficial and deep-seated Staphylococcus aureus skin and soft tissue infections in sub-Saharan Africa: a post hoc analysis of the StaphNet cohort

Case Report

Bilateral choroiditis as the only sign of persistent Mycobacterium intracellulare infection following haematogenous spread in an immunocompromised patient

Editorial

The field is moving on: new diagnostic and therapeutic tools presented at the 28th ECCMID 2018

Original Paper

Notifiable infectious diseases in refugees and asylum seekers: experience from a major reception center in Munich, Germany

Original Paper

Prevalence of asymptomatic sexually transmitted infections in HIV-positive men who have sex with men in Germany: results of a multicentre cross-sectional study

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits